Brachial artery vasoreactivity is a predictor of major cardiovascular events in patients with coronary artery disease

被引:0
|
作者
Lekakis, J [1 ]
Protogerou, A [1 ]
Papamichael, C [1 ]
Ikonomidis, I [1 ]
Karatzis, E [1 ]
Aznaouridis, K [1 ]
Pitiriga, V [1 ]
Mavrikakis, M [1 ]
机构
[1] Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
关键词
D O I
10.1016/S0195-668X(03)94457-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:216 / 216
页数:1
相关论文
共 50 条
  • [21] Type 2 diabetes and risk of major cardiovascular events in peripheral artery disease versus coronary artery disease patients
    Saely, C. H.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Sprenger, L.
    Mutschlechner, B.
    Benda, M.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2035 - 2035
  • [22] TYPE 2 DIABETES AND RISK OF MAJOR CARDIOVASCULAR EVENTS IN PERIPHERAL ARTERY DISEASE VERSUS CORONARY ARTERY DISEASE PATIENTS
    Saely, C. H.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Sprenger, L.
    Grabher, V.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2022, 355 : E288 - E289
  • [23] TYPE 2 DIABETES AND RISK OF MAJOR CARDIOVASCULAR EVENTS IN PERIPHERAL ARTERY DISEASE VERSUS CORONARY ARTERY DISEASE PATIENTS
    Saely, Christoph H.
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Sprenger, Lukas
    Grabher, Valentin
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1543 - 1543
  • [24] Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease
    Greiner, DZ
    Personius, BE
    Andrews, TC
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (02): : 247 - +
  • [25] Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease
    von Haehling, Stephan
    Papassotiriou, Jana
    Morgenthaler, Nils G.
    Hartmann, Oliver
    Doehner, Wolfram
    Stellos, Konstantinos
    Wurster, Thomas
    Schuster, Andreas
    Nagel, Eike
    Gawaz, Meinrad
    Bigalke, Boris
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 162 (01) : 27 - 32
  • [26] Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease
    Wheeler, Matt
    Chan, Noel
    Eikelboom, John
    FUTURE CARDIOLOGY, 2020, 16 (06) : 597 - 612
  • [27] Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease
    Logstrup, Brian Bridal
    Olesen, Kevin Kris Warnakula
    Masic, Dzenan
    Gyldenkerne, Christine
    Thrane, Pernille Gro
    Ellingsen, Torkell
    Botker, Hans Erik
    Maeng, Michael
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09) : 1182 - 1188
  • [28] Remnant Cholesterol Predicts Major Cardiovascular Events in Coronary Artery Disease Patients with NAFLD
    Plattner, Thomas
    Larcher, Barbara
    Mader, Arthur
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2024, 73
  • [29] The impact of chronic kidney disease as a predictor of major cardiac events in patients with no evidence of coronary artery disease
    Furuhashi, Tatsuhiko
    Moroi, Masao
    Joki, Nobuhiko
    Hase, Hiroki
    Masai, Hirofumi
    Kunimasa, Taeko
    Nakazato, Ryo
    Fukuda, Hiroshi
    Sugi, Kaoru
    JOURNAL OF CARDIOLOGY, 2010, 55 (03) : 328 - 336
  • [30] IMPACT OF COMORBID CORONARY ARTERY DISEASE AND SEVERE PERIPHERAL ARTERY DISEASE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Ting, Windsor
    Zhao, Qi
    Haskell, Lloyd
    Lurie, Fedor
    Berger, Jeffrey
    Eapen, Zubin
    Valko, Matthew
    Alas, Veronica
    Rich, Kelly
    Crivera, Concetta
    Schein, Jeff
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1390 - 1390